Cirrhosis of the Liver and Incidence of associated Osteoporosis

Ali Haider Aslam, Sahar Nabeel Akbar, Faisal Rana



Objective: The main aim of this study is to find the incidence of osteoporosis (a bone weakening and breaking disease) in cirrhosis of the liver.

Place and Duration of the Study: This study was carried out in services hospital Lahore in a period of 8 months form May 2018 to December 2018. 

Materials and Methods: Patients were selected who presented in the medical department of Services hospital Lahore. Patients were selected randomly and only those patients were selected who were willing to take part in this study. Mean age of the patients was between 40 t0 70 years and all the patients had cirrhosis of the liver either due to Hepatitis B or C. On DEXA scan T score <2.5 was considered to have osteoporosis. Informed consent was taken from all the patients.

Results:  A total of 50 cases were seen with cirrhosis of the liver and included 18(36%) and 32(64%) males. Mean age of the patients was 47 years. 14(28%) of the patients had osteoporosis. More males 10 (31.25%) were affected with osteoporosis. In age group 56 to 70 years the incidence was much higher. Duration for which the patient had cirrhosis had no significant effect on the incidence.  

Conclusion: Almost every 4th to 5th case of cirrhosis of the liver suffers from osteoporosis which is neglected mostly and not given significance. In people with higher age the complication is more frequent.

Full Text:



Runyon BA. A primer on detecting cirrhosis and caring for these patients without causing harm. Int J Hepatol. 2011;2011(1):801-83.

Mumtaz K, Ahmed US, Abid S. Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis. J Coll Physicians Surg Pak. 2010;20(8):514-18.

NakchbandiIA. Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications. World J Gastroenterol. 2014;20(28):9427–38.

Jakobsen A, Laurberg P, Vestergaard P, Andersen S. Clinical risk factors for osteoporosis are common among elderly people in Nuuk, Greenland. Int J Circumpolar Health. 2013;72(8):01-07.

Yadav, A, CareyEJ. Osteoporosis in chronic liver disease. NutrClinPract. 2013;28:12-14.

Kaemmerer D, Schmidt B, Lehmann G, Wolf G, Settmacher U, Hommann M. Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation. Transplant Res. 2012;1(1):01-07.

Javed M,Saeed A,Khan IM,Hameed K,Rehman S,Khattak AK, et al. Frequency of osteoporosis in patients with cirrhosis due to hepatitis B and hepatitis C: a study of 100 cases. J Ayub Med Coll Abbottabad.2009;21(3):51-3.

Cijevschi C, Mihai C, Zbranca E, Gogalniceanu P. Osteoporosis in liver cirrhosis. Raomanian J Gastroenterol. 2005;14(4):337-41.

Gallego-Rojo FJ, Gonzalez-Calvin JL, MunozTorres M. Bone mineral density, serum insulin like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695–9.

Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH. Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 2004;10:648–53.

Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005;11:1843–7.

Isoniemi H, Appleberg J, Nilsson CG. Transdermal estrogen therapy protects postomenopausal liver transplant women from osteoporosis. A 2-year follow-up study.J Hepatol. 2001;34(2):299-305.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.